EVARF — Lombard Medical Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Lombard Medical announces completion of restructuring, implementation of strategic plan
Brief: Lombard Medical names Kurt Lemvigh CEO
Brief: Lombard Medical Q4 global revenue $2.4 million, FY 2016 revenue $12.2 mln
Brief: Lombard Medical CEO Simon Hubbert steps down
Brief: Lombard Medical announces regulatory approval in for intelliflex LP delivery system
Brief: Lombard Medical and MicroPort Scientific Corporation announce strategic partnership and investment agreement
Brief: Lombard Medical Q3 loss per share $0.37
Brief: Lombard Medical reports Q2 loss per share $0.42
Brief: Lombard Medical - Rescheduled Q2 report
Brief: Lombard Medical launches altura endovascular stent graft system in Netherlands and Spain
Brief: Lombard Medical provides update on controlled launch of new Altura endovascular stent graft in Europe
Brief: Lombard Medical wins Australia approval for aneurysm device
Brief: Lombard Medical releases results from altura endograft system clinical evaluation
Brief: Lombard Medical Inc Q1 loss per share $0.38
Brief: Lombard medical provides update on new Altura Endovascular stent graft launch
Brief: Lombard Medical posts Q4 loss $0.58/shr
Brief: Lombard Medical Q4 revenue $2.9 mln
Brief: Lombard Medical presents data from 3-year follow up of U.S. PYTHAGORAS pre-marketing approval trial of Aorfix
Brief: Lombard Medical plans to file for FDA approval of Intelliflex in early December after positive results